| Literature DB >> 27258254 |
Eric J Mersereau1, Cody A Boyle2, Shelby Poitra3, Ana Espinoza4, Joclyn Seiler5, Robert Longie6, Lisa Delvo7, Megan Szarkowski8, Joshua Maliske9, Sarah Chalmers10, Diane C Darland11, Tristan Darland12.
Abstract
A sizeable portion of the societal drain from cocaine abuse results from the complications of in utero drug exposure. Because of challenges in using humans and mammalian model organisms as test subjects, much debate remains about the impact of in utero cocaine exposure. Zebrafish offer a number of advantages as a model in longitudinal toxicology studies and are quite sensitive physiologically and behaviorally to cocaine. In this study, we have used zebrafish to model the effects of embryonic pre-exposure to cocaine on development and on subsequent cardiovascular physiology and cocaine-induced conditioned place preference (CPP) in longitudinal adults. Larval fish showed a progressive decrease in telencephalic size with increased doses of cocaine. These treated larvae also showed a dose dependent response in heart rate that persisted 24 h after drug cessation. Embryonic cocaine exposure had little effect on overall health of longitudinal adults, but subtle changes in cardiovascular physiology were seen including decreased sensitivity to isoproterenol and increased sensitivity to cocaine. These longitudinal adult fish also showed an embryonic dose-dependent change in CPP behavior, suggesting an increased sensitivity. These studies clearly show that pre-exposure during embryonic development affects subsequent cocaine sensitivity in longitudinal adults.Entities:
Keywords: and behavior; cardiovascular physiology; cocaine; zebrafish
Mesh:
Substances:
Year: 2016 PMID: 27258254 PMCID: PMC4926381 DOI: 10.3390/ijms17060847
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Experimental design of cocaine treatment and analysis of five-day larval zebrafish. A schematic showing the time course of embryonic drug exposure, imaging and longitudinal analysis is shown in (A); (B) shows an example of body length and eye diameter measurements made under bright field illumination; (C) shows the same fish under fluorescence illumination, focusing specifically on the brain at higher magnification. The tracing outlines the telencephalon (Tel), the diencephalon (Dien, which actually includes the optic tectum, midbrain and cerebellum), and the hindbrain (Hind, which includes the rhombencephalon), with sample area measurements given for each region.
Morphometry of embryonic zebrafish clutches treated with cocaine. Larval fish treated with different doses of cocaine were inspected for percentage of hatched individuals at 48 h post fertilization (hpf) and then imaged for size analysis at 5 days post fertilization (dpf) One-way ANOVA with Dunnett’s post-test was used to compare embryonic treatment groups to the untreated control fish. For percentage hatched, values were arcsin transformed before statistical evaluation, p < 0.0001, F = 7.69, df = 47, * p < 0.05, ** p < 0.01, and *** p < 0.001 when compared to untreated fish. For body size p < 0.9651, F = 0.145, and df = 214. For embryonic eye diameter (size), p < 0.123, F = 1.834, and df = 221. For telencephalic (Tel.) area p < 0.015, F = 3.24, df = 110, * p < 0.05 when compared to untreated fish. For the diencephalon (Dien.) area, p < 0.145, F = 1.745, and df = 122. For hind brain (Hind.), p < 0.149, F = 1.727, and df = 114. For acridine orange positive (AO+) cells in the telencephalon, p < 0.891, F = 0.279, and df = 109. For AO+ cells in the diencephalon, p < 0.113, F = 1.92, and df = 109.
| Embryonic Treatment Condition | 0 mg/L Cocaine | 2.5 mg/L Cocaine | 5.0 mg/L Cocaine | 10.0 mg/L Cocaine | 20.0 mg/L Cocaine |
|---|---|---|---|---|---|
| % Hatched by 48 hpf | 16 ± 15.5 | 39.5 ± 21.3 | 51.5 ± 13.8 * | 59.1 ± 19.5 ** | 65.5 ± 28.9 *** |
| Body size (mm) | 3.97 ± 0.16 | 3.94 ± 0.15 | 3.96 ± 0.19 | 3.95 ± 0.21 | 3.95 ± 0.13 |
| Eye Size (mm) | 0.352 ± 0.016 | 0.344 ± 0.014 | 0.351 ± 0.016 | 0.346 ± 0.023 | 0.351 ± 0.16 |
| Tel. Area (mm2) | 0.0306 ± .0028 | 0.0294 ± 0.0026 | 0.0292 ± 0.0026 | 0.0283 ± 0.0025 * | 0.0280 ± 0.0035 * |
| Dien. Area (mm2) | 0.117 ± 0.009 | 0.111 ± 0.006 | 0.112 ± 0.010 | 0.111 ± 0.011 | 0.113 ± 0.013 |
| Hind. Area (mm2) | 0.0499 ± 0.0060 | 0.0503 ± 0.0058 | 0.0495 ± 0.0057 | 0.0463 ± 0.0035 | 0.0494 ± 0.0049 |
| AO+ Tel AO+ Dien | 6.41 ± 0.97 5.27 ± 1.34 | 6.96 ± 1.09 5.68 ± 0.91 | 7.5 ± 0.87 9.00 ± 0.87 | 6.55 ± 0.83 7.57 ± 1.51 | 6.36 ± 0.73 6.64 ± 0.69 |
Figure 2Cocaine treatment decreases telencephalic area of zebrafish larvae. There was a readily observed decrease in telencephalic size seen after treatment with the highest doses of cocaine. Panels A and B provide a comparison between untreated fish (A) and siblings treated with 20 mg/L cocaine (B); In (C), results from several experiments were combined, with brain size expressed as a percentage of untreated controls. Brain size was reduced on average 7% by treatment with 20 mg/L cocaine. Error bars signify ± SEM, * p < 0.05 relative to control and ** p < 0.01 relative to untreated control.
Figure 3Cocaine treatment during development alters heart rate in zebrafish larvae. The histogram shows data from one of three experiments measuring heart rate in zebrafish larvae exposed to different doses of cocaine for three days and then allowed one day of recovery before testing. Cocaine induced a bell-shaped dose response curve in larval baseline heart rate, with the maximal effect seen after treatment with 10 mg/L (error bars indicate ± SEM, * indicates p < 0.05, ** indicates p < 0.01, *** indicates p < 0.001 compared to untreated controls, n = 8 for each condition).
Overall health of longitudinal adults treated with cocaine as embryos. Fish treated with one-way ANOVA with Dunnett’s post-test was used to compare embryonic treatment groups to the untreated control fish. For percentage survival at 8–10 months, p < 0.98, F = 0.080, df = 28. For the percentage of males, p < 0.55, F = 0.7748, df = 34. Fish were classified as either male or female, even in cases where the sex was ambiguous therefore the percentage of females can be inferred from this data as well. For body length (Len.), p < 0.205, F = 1.52, and df = 132. For body weight (Wt.), p < 0.420, F = 0.98, df = 132. For telencephalic area (Tel. Area), p < 0.16, F = 1.55, df = 84. For Baseline Heart Rate (HR), p < 0.7704, F = 0.4522, df = 60.
| Embryonic Treatment Condition | 0 mg/L Cocaine | 2.5 mg/L Cocaine | 5.0 mg/L Cocaine | 10.0 mg/L Cocaine | 20.0 mg/L Cocaine |
|---|---|---|---|---|---|
| Survival at 8–10 months | 61.5% ± 7.8 | 63.5% ± 7.4 | 62.7% ± 7.6 | 63.2% ± 13.2 | 66.8% ± 11.2 |
| Percentage of Males | 34.9% ± 14.1 | 50.3% ± 8.7 | 55.2% ± 11.0 | 43.8% ± 12.9 | 62.5% ± 9.2 |
| Body Len. (cm) | 3.6 ± 0.1 | 3.8 ± 0.3 | 3.7 ± 0.2 | 3.8 ± 0.2 | 3.6 ± 0.2 |
| Body Wt. (g) | 0.45 ± 0.07 | 0.44 ± 0.10 | 0.48 ± 0.10 | 0.43 ± 0.09 | 0.44 ± 0.13 |
| Tel. Area (mm2) | 1.86 ± 0.21 | 1.98 ± 0.22 | 1.97 ± 0.3 | 2.09 ± 0.27 | 2.11 ± 0.38 |
| Baseline HR | 138.3 ± 9.5 | 144.5 ± 8.0 | 132.9 ± 6.2 | 138.6 ± 6.5 | 130.5 ± 9.8 |
Figure 4Embryonic cocaine exposure alters cardiovascular sensitivity to isoproterenol (A) and cocaine (B) in longitudinal adults. The heart rate of longitudinal adults was determined by measuring the ECGs. Baseline heart rate in longitudinal adults treated with cocaine as larvae was no different from untreated controls (Table 2). However, the response to isoproterenol, a ß1 agonist, was lower in longitudinal fish that were treated with cocaine as larvae than in fish that did not receive cocaine. The histogram in panel A shows the isoproterenol-induced change from baseline heart rate in one of three experiments all showing similar results. The effect of larval pre-exposure to cocaine on the adult isoproterenol response was U-shaped, with a maximal inhibition seen in fish previously treated with 10 mg/L cocaine (Error bars indicate ± SEM, * indicates p < 0.05, ** indicates p < 0.01, compared to untreated controls, n = 7 for each condition). Longitudinal fish from the different embryonic treatment groups were also challenged with 5 mg/L cocaine and their ECGs measured. The histogram in panel B shows the effect of larval pre-exposure to cocaine on subsequent adult cardiovascular response to the drug. The response by the different longitudinal groups is bell-shaped, with a maximal effect seen in fish pre-exposed to 10 mg/L cocaine as larvae (Bars indicate ± SEM, * indicates p < 0.01 when compared to fish pre-exposed to 20 mg/L, n = 18 for 0 and 20 mg/L cocaine, n = 16 for 2.5 and 10 mg/L, and n = 15 for 5 mg/L cocaine).
Figure 5Pre-exposure to cocaine in larval fish affects cocaine-induced conditioned place preference (CPP) in longitudinal adults. This histogram represents data from four experiments combined testing CPP in longitudinal adults raised from larvae exposed to different doses of cocaine. Fish from all embryonic treatment groups not treated with cocaine as adults were combined into a single group for comparative purposes (Unt CPP). CPP was tested using 5 mg/L for all embryonic treatment groups and is expressed as a change in the percentage of time spent in the conditioning chamber before and after drug exposure. Cocaine pre-exposure during development results in a bell-shaped response curve for CPP in longitudinal adults. All longitudinal groups showed significantly higher CPP than untreated controls except for fish previously exposed to 20 mg/L cocaine. The maximal response observed in fish previously exposed to 10 mg/L and this group had the lowest p-value and was also significantly higher than the 20 mg/L group (p < 0.05). (Error bars represent ± SEM, * indicates p < 0.05, *** indicates p < 0.001 when compared to the untreated control group, n = 33 for untreated controls, n = 44 for 0 mg/L cocaine, n = 22 for 2.5 mg/L, n = 22 for 5 mg/L, n =30 for 10 mg/L, and n = 37 for 20 mg/L).